BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29703757)

  • 1. Telomerase promoter mutations and copy number alterations in solitary fibrous tumours.
    Lin Y; Seger N; Tsagkozis P; Hesla AC; Ghaderi M; Chen Y; Ehnman M; Warsito D; Wejde J; Larsson O; Haglund F
    J Clin Pathol; 2018 Sep; 71(9):832-839. PubMed ID: 29703757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERT promoter mutations in solitary fibrous tumour.
    Demicco EG; Wani K; Ingram D; Wagner M; Maki RG; Rizzo A; Meeker A; Lazar AJ; Wang WL
    Histopathology; 2018 Nov; 73(5):843-851. PubMed ID: 29985536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT promoter mutations and prognosis in solitary fibrous tumor.
    Bahrami A; Lee S; Schaefer IM; Boland JM; Patton KT; Pounds S; Fletcher CD
    Mod Pathol; 2016 Dec; 29(12):1511-1522. PubMed ID: 27562490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential.
    Akaike K; Kurisaki-Arakawa A; Hara K; Suehara Y; Takagi T; Mitani K; Kaneko K; Yao T; Saito T
    Hum Pathol; 2015 Mar; 46(3):347-56. PubMed ID: 25582503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcome.
    Machado I; Nieto Morales MG; Cruz J; Lavernia J; Giner F; Navarro S; Ferrandez A; Llombart-Bosch A
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour.
    Koelsche C; Schweizer L; Renner M; Warth A; Jones DT; Sahm F; Reuss DE; Capper D; Knösel T; Schulz B; Petersen I; Ulrich A; Renker EK; Lehner B; Pfister SM; Schirmacher P; von Deimling A; Mechtersheimer G
    Histopathology; 2014 Nov; 65(5):613-22. PubMed ID: 24702701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
    Bertero L; Anfossi V; Osella-Abate S; Disanto MG; Mantovani C; Zenga F; Rudà R; Garbossa D; Soffietti R; Ricardi U; Papotti M; Cassoni P
    PLoS One; 2018; 13(9):e0203570. PubMed ID: 30183767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the
    Kouba E; Simper NB; Chen S; Williamson SR; Grignon DJ; Eble JN; MacLennan GT; Montironi R; Lopez-Beltran A; Osunkoya AO; Zhang S; Wang M; Wang L; Tran T; Emerson RE; Baldrige LA; Monn MF; Linos K; Cheng L
    J Clin Pathol; 2017 Jun; 70(6):508-514. PubMed ID: 27802414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous tumours: a comparative histological, immunohistochemical and molecular study of 36 cases.
    Kao YC; Lin PC; Yen SL; Huang SC; Tsai JW; Li CF; Tai HC; Lan J; Chuang IC; Yu SC; Huang HY
    Histopathology; 2016 Mar; 68(4):492-501. PubMed ID: 26154686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality.
    Lin Y; Seger N; Chen Y; Hesla AC; Wejde J; Ghaderi M; Tsagkozis P; Larsson O; Haglund F
    Mod Pathol; 2018 Dec; 31(12):1834-1841. PubMed ID: 30065261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and molecular features of solitary fibrous tumor of the extremities: clinical correlation.
    Bianchi G; Sambri A; Pedrini E; Pazzaglia L; Sangiorgi L; Ruengwanichayakun P; Donati D; Benassi MS; Righi A
    Virchows Arch; 2020 Mar; 476(3):445-454. PubMed ID: 31463729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of published risk models for prediction of outcome in patients with extrameningeal solitary fibrous tumour.
    Demicco EG; Griffin AM; Gladdy RA; Dickson BC; Ferguson PC; Swallow CJ; Wunder JS; Wang WL
    Histopathology; 2019 Nov; 75(5):723-737. PubMed ID: 31206727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
    Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
    Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary fibrous tumors of the head and neck region revisited: a single-institution study of 20 cases and review of the literature.
    Baněčková M; Martínek P; Skálová A; Mezencev R; Hadravský L; Michal M; Švajdler M
    Hum Pathol; 2020 May; 99():1-12. PubMed ID: 32217090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary fibrous tumor: a case series identifying pathological adverse factors-implications for risk stratification and classification.
    Machado I; Morales GN; Cruz J; Lavernia J; Giner F; Navarro S; Ferrandez A; Llombart-Bosch A
    Virchows Arch; 2020 Apr; 476(4):597-607. PubMed ID: 31529158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAB2-STAT6 gene fusion and STAT6 immunoexpression in extrathoracic solitary fibrous tumors: the association between fusion variants and locations.
    Chuang IC; Liao KC; Huang HY; Kao YC; Li CF; Huang SC; Tsai JW; Chen KC; Lan J; Lin PC
    Pathol Int; 2016 May; 66(5):288-96. PubMed ID: 27039712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.
    Fritchie KJ; Jin L; Rubin BP; Burger PC; Jenkins SM; Barthelmeß S; Moskalev EA; Haller F; Oliveira AM; Giannini C
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):263-71. PubMed ID: 26883114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAB2-STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors.
    Tai HC; Chuang IC; Chen TC; Li CF; Huang SC; Kao YC; Lin PC; Tsai JW; Lan J; Yu SC; Yen SL; Jung SM; Liao KC; Fang FM; Huang HY
    Mod Pathol; 2015 Oct; 28(10):1324-35. PubMed ID: 26226844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a series of solitary fibrous tumors, including immunohistochemical expression of STAT6 and NATB2-STAT6 fusion transcripts, using Reverse Transcriptase(RT)-Polymerase chain reaction(PCR) technique: An Indian experience.
    Rekhi B; Shetty O; Tripathi P; Bapat P; Ramadwar M; Bajpai J; Puri A
    Pathol Res Pract; 2017 Nov; 213(11):1404-1411. PubMed ID: 28869107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological differences between variants of the NAB2-STAT6 fusion gene in solitary fibrous tumors of the meninges and extra-central nervous system.
    Nakada S; Minato H; Nojima T
    Brain Tumor Pathol; 2016 Jul; 33(3):169-74. PubMed ID: 27271270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.